Actually the RBC analyst was correct or close to it! The $1 million revenue coming into SNY was stocking the drug with the retailers--CVS, Walgreen, etc. The analyst stated--'estimated prescriptions written' as being worth $250,000. If these numbers are anywhere near being correct, retailers inventory is still 75% of 1Q sales by SNY, and at this this rate of adoption there will be no need for retailers to stock any inventory for the 2nd Q. Meaning no revenue coming in for the next three months. I hope I'm wrong--but one shouldn't confuse inventory vs actual sales to end users. SNY makes money selling to retailers as they don't sell direct to patients. SNY has a lot of work cut out for them--going forward! I hope they make it!
What is this --the tenth time they've rebranded their product line. Amazing, how many times that announce partnership deals that will make the millions, only to move now back to self marketing as being their solution. Did I say--SOLUTION!
The Yahoo average daily volume is an average of trading based on a rolling 3month average of trading. In the case of BLCM, the stock has only traded since mid-December, and the first day of trading there were 9Million shares traded--in the interim time frame the volume exceeded 500,000 shares on numerous dates. So the average of 800,000 is real----so you shouldn't expect 'every day' to see 800,000 shares traded.